Endogenous vasopressin and baroreflex mechanisms.
This article reviews the anatomical and functional evidence for ascending pathways from specific brain regions to the PVN and SON which could influence AVP release. The majority of evidence favours the main projection being from a region in the caudal VLM which may coincide with the noradrenergic neurons of the A1 cell group. However, the transmitter(s) involved have yet to be identified, and whether the pathway is excitatory and/or inhibitory remains to be fully resolved. Anatomical and functional evidence is reviewed for descending projections from the SON and PVN to specific brain regions involved in cardiovascular control, and their possible involvement in baroreflex mechanisms is discussed. However, there is little unequivocal evidence that AVP is the main neurotransmitter utilized by descending projections from PVN to NTS and DMX. While, in some situations, circulating endogenous AVP exerts cardiovascular effects, details of its putative influences on baroreflex mechanisms are lacking.
D000818:Animals; D001127:Arginine Vasopressin / Q000378:metabolism / Q000502:physiology*; D001794:Blood Pressure; D002320:Cardiovascular Physiological Phenomena; D006339:Heart Rate; D009434:Neural Pathways; D011311:Pressoreceptors / Q000502:physiology*; D012018:Reflex; D013045:Species Specificity
D001127:Arginine Vasopressin